Form 4 for ICUI ICU MEDICAL INC/DE
Accepted 2024-02-14 00:00:00 ET · period of report 2024-02-12 · accession 0001410442-24-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-02-14 | 2024-02-12 | ICUI | Jain Vivek | COB, CEO, Dir | F - Tax | $104.02 | -37.3K | 88.7K | -30% | -$3.88M |
| D | 2024-02-14 | 2024-02-12 | ICUI | Jain Vivek | COB, CEO, Dir | M - OptEx | $58.79 | +146.4K | 170.0K | +618% | +$8.60M |
| DI | 2024-02-14 | 2024-02-12 | ICUI | Jain Vivek | COB, CEO, Dir | M - OptEx | $58.79 | +66.0K | 126.0K | +110% | +$3.88M |
| D | 2024-02-14 | 2024-02-12 | ICUI | Jain Vivek | COB, CEO, Dir | F - Tax | $104.02 | -82.7K | 87.3K | -49% | -$8.61M |
| D | 2024-02-14 | 2024-02-12 | ICUI | Jain Vivek | COB, CEO, Dir | M - OptEx | $0.00 | -146.4K | 0 | -100% | $0 |
| DI | 2024-02-14 | 2024-02-12 | ICUI | Jain Vivek | COB, CEO, Dir | M - OptEx | $0.00 | -66.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-12 | F | D | 37,302 | $104.02 | 88,698 | I | — | — | (F3) Represents a "net exercise" of outstanding stock options. The trusts received 28,698 shares of common stock on net exercise of option to purchase 66,000 shares of common stock. The company withheld 37,302 shares of common stock underlying the option for payment of the exercise price, using the closing stock price on February 12, 2024 of $104.02. |
| 2 | Common | Common Stock | 2024-02-12 | M | A | 146,366 | $58.79 | 170,043 | D by Trust | — | — | |
| 3 | Common | Common Stock | 2024-02-12 | M | A | 66,000 | $58.79 | 126,000 | I | — | — | |
| 4 | Common | Common Stock | 2024-02-12 | F | D | 82,725 | $104.02 | 87,318 | D by Trust | — | — | (F2) Represents a "net exercise" of outstanding stock options. The reporting person received 63,641 shares of common stock on net exercise of option to purchase 146,366 shares of common stock. The company withheld 82,725 shares of common stock underlying the option for payment of the exercise price, using the closing stock price on February 12, 2024 of $104.02. |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-02-12 | M | D | 146,366 | $0.00 | 0 | D by Trust | $58.79 · 2018-02-13 to 2024-02-24 | 146,366 Common Stock | (F4) These non-qualified stock options were granted on 2/24/2014 with a ten year life with an expiration date of 2/24/2024. |
| 6 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-02-12 | M | D | 66,000 | $0.00 | 0 | I | $58.79 · 2018-02-13 to 2024-02-24 | 66,000 Common Stock | (F4) These non-qualified stock options were granted on 2/24/2014 with a ten year life with an expiration date of 2/24/2024. |